ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Fate Therapeutics (FATE) Technical (Analysis) Reports Fate Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Fate Therapeutics (FATE)

Technical Analysis Report for USA stock FATE Fate Therapeutics. Dated: 20 Aug 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in USA stock exchange

If you are looking for Tomorrow's Movement Predictions for USA stock FATE Fate Therapeutics then click here. or read Experts views on Fate Therapeutics or Forecast & share price targets of Fate Therapeutics

Fate Therapeutics Opened at 2.79 and Closed at: 2.44, which is -8.61% of previous session's close. It moved within a range of 2.44 and 2.79
The session was a Bearish session with an average volume of 899246, which is -35.3% of previous session's volumes.

  • Even though the stock has fallen, but its mid term trend is positive and in an uptrend.

A Golden cross was found 7 days back on short term averages

Support for tomorrow is 2.27 and resistance for tomorrow is 2.62
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 2.32, 2.21 resistance for tomorrow's hourly charts is 2.67, 2.91

10 Day SMA for Fate Therapeutics (FATE) is 2.64 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Fate Therapeutics (FATE) is 2.55 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Fate Therapeutics (FATE) is 2.54 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 2.17 and the stock is trading above these levels. This is a good sign for its long term trend

200 Day SMA Fate Therapeutics is 1.66 and stock is trading above these levels. This is a good sign for its long term trend

20 DMA of Fate Therapeutics is at 2.55 and 200 DMA is at 1.66, while 50 DMA and 100 DMA are at 2.54 and 2.17 respectively

Fate Therapeutics (FATE) moving average of 20 SMA is at 2.55 and 20 EMA is at 2.58

Fate Therapeutics (FATE) moving average of 50 SMA is at 2.54 and 50 EMA is at 2.5

Fate Therapeutics (FATE) moving average of 100 SMA is at 2.17 and 100 EMA is at 2.26

Fate Therapeutics (FATE) moving average of 200 SMA is at 1.66 and 200 EMA is at 1.92

Fate Therapeutics has performed better than Zoetis Inc in short term. Holding Fate Therapeutics could be a better choice for now!

Tenet Healthcare has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Tenet Healthcare, about 15.66% more returns!

Arcus Biosciences has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Arcus Biosciences, about 2.63% more returns!

Fate Therapeutics has performed better than Mckesson Corporation in short term. Holding Fate Therapeutics could be a better choice for now!

Eli Lilly has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Eli Lilly, about 2.91% more returns!

Verastem Inc has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Verastem Inc, about 11.49% more returns!

Tandem Diabetes has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Tandem Diabetes, about 30.59% more returns!

China Sxt has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in China Sxt, about 5948.76% more returns!

Phio Pharmaceuticals has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Phio Pharmaceuticals, about 15.11% more returns!

Phibro Animal has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Phibro Animal, about 2.14% more returns!

National Research has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in National Research, about 2.47% more returns!

Nektar Therapeutics has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Nektar Therapeutics, about 4.15% more returns!

Iovance Biotherapeutics has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Iovance Biotherapeutics, about 78.88% more returns!

Incyte Corporation has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Incyte Corporation, about 6.88% more returns!

Dermira Inc has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Dermira Inc, about 19.96% more returns!

Corcept Therapeutics has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Corcept Therapeutics, about 25.7% more returns!

Fate Therapeutics Technical analysis of indicators

Price action analysis of Fate Therapeutics (FATE) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.

ADX buy sell signal for Fate Therapeutics stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.

MACD generated a SELL signal for Fate Therapeutics in short term but the sell signal is initial and weak.

Fate Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.

Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down

CCI has generated a SELL signal for Fate Therapeutics in short term and SELL signal is strong!

RSI is generating a SELL signal in short term and selling is picking up momentum.

MRSI is in positive zone. This is a BUY zone

Stock of Fate Therapeutics is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 2.66 and Fate Therapeutics FATE stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.

People seem to be coming out and selling the Fate Therapeutics FATE stock. Volume based technical analysis of Fate Therapeutics FATE stock is negative.

Fate Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for USA stock FATE Fate Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And FATE Experts View which covers a lot of information including buying and selling signals

FATE future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Fate Therapeutics or View Candle Stick Charts here

Chart Fate Therapeutics (FATE)  Technical (Analysis) Reports Fate Therapeutics [

Videos related to: Fate Therapeutics (FATE) Technical (Analysis) Reports Fate Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Fate Therapeutics (FATE)  Technical (Analysis) Reports Fate Therapeutics [

 

Back to top